NERV - minervaneurosciences.com Uzoq muddatli majburiyatlarning kapitalga nisbati
Minerva Neurosciences neyrofarmakologiya sohasidagi barqaror talabga tayanadi, garchi sanksiyalar xomashyolarni yetkazib berishni murakkablashtirsa-da. Ushbu uzoq muddatli qarzning kapitalga nisbati grafigi moliyaviy barqarorlikni namoyish etadi, bunda 0.00 darajasi joriy qiymatni ifodalaydi. Tartibga soluvchi organlar tomonidan rad etilishi va moliyalashtirish yetishmovchiligidan kelib chiqadigan bankrotlik xatarlarini hisobga olgan holda, bu juda muhimdir. Biroq, shizofreniya terapiyasi bozori yangi yechimlarga juda muhtoj bo'lgani sababli, o'sish potentsiali juda yuqoridir.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_NERV_-_Minerva-Neurosciences_-_Long-Term-Debt-to-Equity-Ratio "NERV: Minerva Neurosciences, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
Minerva Neurosciences (NERV) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Minerva Neurosciences|NERV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati minervaneurosciences.com|NERV - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Minerva Neurosciences, Inc.|NERV - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Minerva Neurosciences
Fundamental baholash:Minerva Neurosciences Inc
Investorlar emitentning moliyaviy barqarorligini uning qarz mablag'lariga bog'liqlik darajasi orqali baholaydilar. Minerva Neurosciences (NERV) uchun budjetni muvozanatlash psixotrop dori vositalarining uzoq muddatli klinik sinovlari muvaffaqiyatsizligi bilan bog'liq xatarlar tufayli juda muhimdir. Joriy uzoq muddatli qarzlarning kapitalga nisbati bir yildan ortiq muddatga ega majburiyatlarning kapitalga nisbatan ulushini aks ettiradi. Ushbu koeffitsiyentning pasayishi defolt ehtimolini minimallashtiradi. Ushbu aktiv yuqori xavfli biofarmatsevtika startaplari toifasiga kiradi.
Minerva Neurosciences raqobatchilari
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|CPRX (Catalyst Corp) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati DNLI|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com|BHVN (Biohaven) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati AMLX (Amylyx Pharmaceuticals Inc)|TRVI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Praxis Corp PRAX|AVXL (Anavex Life Sciences) - Uzoq muddatli qarzning kapitalga nisbati|CBLL: Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Prothena Corp PRTA|Uzoq muddatli qarzning kapitalga koeffitsiyenti Alector|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Omeros Corp.|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzning kapitalga nisbati acimmune.com ACIU|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc.|Neumora - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Scilex Holding Co. (SCLX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|TVGN - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati ACOG|Uzoq muddatli majburiyatlarning kapitalga nisbati cogrx.com|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati SAVA|Assertio Holdings, Inc. (ASRT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti COYA (coyatherapeutics.com)|VTGN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Ovid Therapeutics Inc - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ABOS (Acumen Pharmaceuticals, Inc.)|CRVO - Uzoq muddatli qarzdorlikning kapitalga nisbati|ATHE (alteritytherapeutics.com) - Uzoq muddatli qarzning kapitalga nisbati|Clene (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PEPG: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati jupiterneurosciences.com|Relmada Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ANVS (Annovis Bio Inc)|GRCE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Firefly Neuro AIFF|KLTO: Uzoq muddatli qarzning kapitalga nisbati|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati RVPH|MTVA (MetaVia) - Uzoq muddatli majburiyatlarning kapitalga nisbati|NRXS: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati HSDT|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. PASG|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi bionomics.com.au (NEUP)|ATHA: Uzoq muddatli qarzning kapitalga nisbati|Addex Therapeutics Ltd. - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Alzamend (ALZN)|Cyclerion Therapeutics (CYCN) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA (Pasithea Therapeutics Corp.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc (CRGT)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Avenue Therapeutics Inc.|Brainstorm Cell Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cara Therapeutics Inc CARA|Uzoq muddatli qarzning o'z kapitaliga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Intra-Cellular (ITCI)|LBPH: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati MRNS|NKGN (NKGen Biotech Corp) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|Uzoq muddatli qarzning o'z kapitaliga nisbati sagerx.com|SNPX (Synaptogenix) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TRVN (Trevena Inc.)|VIGL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Anew Medical Inc. WENA|CERE (Cerevel Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati